Macquarie Group’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Buy
25,183
+1,978
+9% +$228K 0.01% 498
2026
Q1
$2.77M Sell
23,205
-6,319
-21% -$829K 0.02% 471
2025
Q4
$4.02M Sell
29,524
-15,788
-35% -$2.27M 0.02% 442
2025
Q3
$6.25M Buy
45,312
+21,534
+91% +$2.99M 0.01% 908
2025
Q2
$3.08M Sell
23,778
-6,270
-21% -$759K ﹤0.01% 1097
2025
Q1
$3.59M Buy
30,048
+4,285
+17% +$531K ﹤0.01% 1057
2024
Q4
$1.9M Buy
25,763
+12,338
+92% +$1.56M ﹤0.01% 1213
2024
Q3
$1.81M Hold
13,425
﹤0.01% 1260
2024
Q2
$1.82M Sell
13,425
-579
-4% -$78.8K ﹤0.01% 1258
2024
Q1
$1.81M Sell
14,004
-853
-6% -$103K ﹤0.01% 1247
2023
Q4
$1.7M Sell
14,857
-26,910
-64% -$2.69M ﹤0.01% 1274
2023
Q3
$3.8M Buy
41,767
+8,617
+26% +$889K ﹤0.01% 994
2023
Q2
$3.73M Buy
33,150
+25,352
+325% +$2.68M ﹤0.01% 1000
2023
Q1
$817K Sell
7,798
-2,330
-23% -$243K ﹤0.01% 1390
2022
Q4
$1.12M Buy
10,128
+4,429
+78% +$464K ﹤0.01% 1379
2022
Q3
$498K Buy
5,699
+1,370
+32% +$125K ﹤0.01% 1527
2022
Q2
$338K Sell
4,329
-206
-5% -$17K ﹤0.01% 1632
2022
Q1
$387 Buy
4,535
+196
+5% +$18.8K ﹤0.01% 1706
2021
Q4
$520K Sell
4,339
-43,245
-91% -$5.37M ﹤0.01% 1649
2021
Q3
$5.88M Buy
47,584
+570
+1% +$73.4K 0.01% 1066
2021
Q2
$5.64M Buy
47,014
+40,492
+621% +$4.62M ﹤0.01% 1104
2021
Q1
$686K Hold
6,522
﹤0.01% 1477
2020
Q4
$663K Sell
6,522
-400
-6% -$37.6K ﹤0.01% 1400
2020
Q3
$583K Buy
6,922
+2,032
+42% +$158K ﹤0.01% 1370
2020
Q2
$317K Sell
4,890
-1,222
-20% -$80.7K ﹤0.01% 1445
2020
Q1
$398K Sell
6,112
-1,008
-14% -$79.4K ﹤0.01% 1323
2019
Q4
$561K Sell
7,120
-3,799
-35% -$296K ﹤0.01% 1377
2019
Q3
$870K Buy
10,919
+7,815
+252% +$614K ﹤0.01% 1260
2019
Q2
$260K Hold
3,104
﹤0.01% 1529
2019
Q1
$245K Hold
3,104
﹤0.01% 1420
2018
Q4
$207K Buy
3,104
+260
+9% +$18K ﹤0.01% 1422
2018
Q3
$228K Sell
2,844
-56
-2% -$4.18K ﹤0.01% 1452
2018
Q2
$195K Hold
2,900
﹤0.01% 1667
2018
Q1
$223K Sell
2,900
-5,100
-64% -$377K ﹤0.01% 1668
2017
Q4
$528K Sell
8,000
-400
-5% -$26.6K ﹤0.01% 1425
2017
Q3
$526K Hold
8,400
﹤0.01% 1432
2017
Q2
$466K Sell
8,400
-5,000
-37% -$260K ﹤0.01% 1307
2017
Q1
$673K Sell
13,400
-700
-5% -$34.1K ﹤0.01% 1267
2016
Q4
$699K Buy
14,100
+12,600
+840% +$639K ﹤0.01% 1255
2016
Q3
$79K Sell
1,500
-1,500
-50% -$73.6K ﹤0.01% 1482
2016
Q2
$134K Buy
3,000
+1,500
+100% +$65.2K ﹤0.01% 1482
2016
Q1
$61K Hold
1,500
﹤0.01% 1464
2015
Q4
$55K Sell
1,500
-3,300
-69% -$119K ﹤0.01% 1446
2015
Q3
$158K Hold
4,800
﹤0.01% 1437
2015
Q2
$178K Hold
4,800
﹤0.01% 1468
2015
Q1
$168K Hold
4,800
﹤0.01% 1435
2014
Q4
$183K Buy
+4,800
New +$176K ﹤0.01% 1421
2014
Q3
Sell
-11,000
Closed -$430K 1607
2014
Q2
$430K Buy
11,000
+8,800
+400% +$329K ﹤0.01% 1337
2014
Q1
$80K Buy
+2,200
New +$80.2K ﹤0.01% 1484
2013
Q4
Sell
-2,200
Closed -$61K 1652
2013
Q3
$61K Hold
2,200
﹤0.01% 1546
2013
Q2
$59K Buy
+2,200
New +$60.7K ﹤0.01% 1501

Other funds holding XYL

Macquarie Group's XYL Position: Q2 2026 in Review

Macquarie Group increased its Xylem (XYL) stake by 8.5% in Q2 2026, buying an estimated $228K and bringing the position to 25,183 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #498.

Macquarie Group first reported a position in XYL in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.25M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Macquarie Group held 25,183 shares of Xylem worth $2.98M as of Q2 2026.
  • Macquarie Group bought 1,978 Xylem shares in Q2 2026, an estimated $228K.
  • Xylem made up 0.01% of Macquarie Group's portfolio in Q2 2026, its #498 holding.
  • Macquarie Group first reported a position in Xylem in Q2 2013 and has held it in 51 quarters since.
  • Macquarie Group's Xylem position peaked at $6.25M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.